1. Ahotupa M, Ruutu M, Mantyla E: Simple methods of qu-antifying ojddation products and antioxidant potential of low density lipoproteins. Clin Biochem 29: 139 (1996).
2. Ahotupa M, Vasankari TJ: Baseline diene conjugation in LDL lipids: An indicator of circulating oxidized LDL. FreeRadical BiolMed27: 1141 (1996).
3. Bettridge DJ, Morrell JM: Lipids and Coronary Heart Di-sease. Chapman and Hail Medical, London (1998).
4. Buege JA and Aust JD: Microsomal lipid peroxidation. Method Enzymol 52: 302 (1978).
5. Doğru-Abbasoğlu S, Kanbağlı Ö, Bulur H, Babalık E, Öztürk S, Aykac-Toker G, Uysal M: Lipid peroxides and antioxidant status in serum of patients with angiographi-cally defined coronary atherosclerosis. Clin Biochem 32: 671 (1999).
6. Esterbauer H, Gebicki J, Puhl H, JUrgens G: The role of peroxidation and antioxidants in oxidative modification of LDL. FreeRadical Biol Med 13: 341 (1992).
7. Grundy SM: Atlas of Lipid Disorders, Cholesterol, Atherosclerosis and Coronary Heart Disease, Gower Medical Publ., New York (1990).
8. Gugliucci A, Menini T, Stahl AJC: Susceptibility to cop-per-enhanced autoxidation of VLDL+LDL fractions from diabetic patients. Biochem Mol Biol İnter 32: 139 (1994).
9. Halevy D, Thiery J, Nagel D, Arnold S, Erdmann E, Höfling B, Cremer P, Seidel D. Increased oxidation of LDL in patients vvith coronary artery disease is indepen-dent from dietary vitamins E and C.Arterioscler Thromb VascBiol 17: 1432 (1997).
10. Halliwell B and Gutteridge JMC: The antioxidants of hu-
man extracellular fluids. Arch Biochem Biophys 280: 1 (1990).
11. Itabe H: Oxidized phospholipids as a new landmark in atherosclerosis. Prog Lipid Res 37: 181 (1998).
12. Jialal I, Devaraj S: Low-density lipoprotein oxidation, antioxidants and atherosclerosis: a clinical biochemistry perspective. Clin Chem 42: 498 (1996).
13. Mehmetçik G, Toker G, Uysal M: Endogenous and copper-induced lipid peroxidation and antioxidant activity of serum in hypercholesterolemic subjects. Horm Metab Res 29: 63 (1997).
14. Özdemirler G, Öztezcan S, Toker G, Uysal M: Peroxida-tion status of erythrocytes and apolipoprotein B contai-ning lipoproteins in hypercholesterolemic subjects. Inter-nat J Vit Nutr Res67:130(1997).
15. Sattler W, Maile E, Kostner GM: Methodological appro-aches for assessing lipid and protein oxidation and modification in plasma and isolated lipoproteins. Method Mol Biol 110: 167(1998).
16. Schwenke DC: Antioxidants and atherogenesis. J Nutr Biochem 9: 424 (1998).
17. Uysal M: Ateroskleroz, kalb-damar hastalıkları ve serbest radikaller. Aktüel Tıp Dergisi 5: 15 (2000).
18. Uysal M, Kanbağlı Ö, Doğru-Abbasoğlu S, Mehmetçik G, Özdemirler G, Aykac-Toker G: Aterosklerozla ilişkili hastalıklarda lipit peroksidasyonu ve antioksidan sistem üzerine incelemeler. Osmangazi Üniversitesi Tıp Fakültesi Dergisi 20: 141 ( 1999)
19. Uzel N, Sivas A, Uysal M, Öz H: Studies on serum pero-xides in normolipidemic and hyperlipidemic individuals. IRCS Med Sci 13: 1039(1985).
20. Van de Vijyer LPL, Kardinaal AFM, Van Duyvenvoorde W, Kruijssen DACM, Grobbee DE, Van Poppel G, Prin-cen HMG: LDL oxidation and extent of coronary atherosclerosis. Aıterioscler Thromb Vasc Biol 18: 193 (1998).
21. Wieland H, Seidel D: A simple specific method for pıe-cipitation of low density lipoproteins. J Lipid Res 24: 904 (1983).
22. Yla-Herttuala S: Is oxidized low-density lipoprotein presem in vivo? Curr Opin Lipidol 9: 337 (1998).
23. Yla-Herttuala S, Palinski W, Rosenfeld ME, Parthasa-rathy S, Carew TE, Butler S, Witztum JL, Steinberg D: Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man. J Clin İnvest 84: 1086 (1989).
24. Zhang A, Vertommen J, Van Gaal L, De Leeuvv I: A ra-pid and simple method for measuring the susceptibility of low-density-lipoprotein and very-low-density-lipopıo-tein to copper-catalyzed oxidation. Clin Chim Açta 227: 159(1994).
Thank you for copying data from http://www.arastirmax.com
